Page last updated: 2024-08-21

azomycin and Myelodysplastic Syndromes

azomycin has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dimitrakopoulou, A; Giannouli, S; Kambas, K; Katsila, T; Kloukina, I; Mouchtouris, V; Pagakis, SN; Patrinos, GP; Poulaki, A; Probert, L; Ritis, K; Stergiou, IE; Tzioufas, AG; Vidali, V; Voulgarelis, M; Xingi, E	1

Other Studies

1 other study(ies) available for azomycin and Myelodysplastic Syndromes

Article	Year
Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology. International journal of molecular sciences, 2021, Apr-15, Volume: 22, Issue:8 Topics: Aged; Aged, 80 and over; Antigens, CD34; Autophagy; Bone Marrow; Cell Differentiation; Cell Lineage; Cell Proliferation; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Male; Middle Aged; Mitophagy; Myelodysplastic Syndromes; Myeloid Cells; Nitroimidazoles; Transcription Factors; Up-Regulation	2021

Article

Year

Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology.

International journal of molecular sciences, 2021, Apr-15, Volume: 22, Issue:8

Topics: Aged; Aged, 80 and over; Antigens, CD34; Autophagy; Bone Marrow; Cell Differentiation; Cell Lineage; Cell Proliferation; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Male; Middle Aged; Mitophagy; Myelodysplastic Syndromes; Myeloid Cells; Nitroimidazoles; Transcription Factors; Up-Regulation

2021